Aminopterin/methotrexate embryofetopathy

A syndrome of developmental anomalies characterized by growth deficiency, facial dysmorphism and skull, limb and neural defects secondary to maternal exposure to aminopterin or methotrexate (MTX) during pregnancy.

Micrognathia

Developmental hypoplasia of the mandible.


Total: 0

                      


(per page)
PMID (PMCID)